Alan Rapraeger awarded $1.9 million grant to study myeloma cell signaling
Alan Rapraeger, MD, professor of human oncology at the University of Wisconsin School of Medicine and Public Health, has been awarded a five-year, $1.9 million R01 grant from the National Cancer Institute to investigate signaling mechanisms that drive myeloma cell proliferation, survival and invasion.
New study shows how cells can be led down non-cancer path
As cells with a propensity for cancer break down food for energy, they reach a fork in the road: They can either continue energy production as healthy cells, or shift to the energy production profile of cancer cells.
Study finds people with Alzheimer’s disease have altered gut bacteria
Changes in gut bacteria could be linked to Alzheimer’s disease, according to a new study from the University of Wisconsin School of Medicine and Public Health.
Zachary Morris earns prestigious NIH Director’s Early Independence Award
The National Institutes of Health (NIH) announced that Dr. Zachary Morris has been awarded $1.25 million as part of the NIH Director’s Early Independence Award.
Study identifies patients who benefit most from dinutuximab-based immunotherapy
Using data from a randomized phase III clinical trial of neuroblastoma patients (treated with or without immunotherapy) performed by the Children’s Oncology Group, researchers from the University of Wisconsin School of Medicine and Public Health found that a subset of patients, identified by the presence of a certain set of genes, were more likely to benefit from the immunotherapy than those patients that did not have that set of genes.
Researchers discover how two gene enhancers control blood cell development
A group of researchers from the University of Wisconsin School of Medicine and Public Health (SMPH) has unearthed a critical process in how healthy red blood cells are produced.
SPORE announces $400,000 in pilot grants for head and neck cancer
The University of Wisconsin Head and Neck SPORE Grant recently awarded pilot funding to nine UW School of Medicine and Public Health researchers for new projects.
Wisconsin researchers awarded $5.3 million for NIH precision medicine research
Three Wisconsin based medical and scientific organizations – Marshfield Clinic Research Institute, University of Wisconsin School of Medicine and Public Health and Medical College of Wisconsin – have collectively been awarded $5,360,832 to help implement in Wisconsin the National Institutes of Health’s (NIH’s) All of Us Research Program that aims to benefit communities across the country.
New pancreatic cancer study uses optical imaging to craft better treatments
Pancreatic cancer research at the University of Wisconsin Carbone Cancer Center (UWCCC) is getting a big boost, thanks to a $3 million grant from the National Cancer Institute.
Study provides cellular explanation for higher risk of prostate cancer in aging men
The link between aging and prostate cancer development is now better understood, based on a study by University of Wisconsin Carbone Cancer Center researchers.
Carbone study find protein that improves immune response in colon cancer
A better understanding of the function of non-cancerous cells and tissue surrounding colon cancer cells is providing a clearer picture of how the immune system recognizes and accesses the cancer site, according to a new study by University of Wisconsin Carbone Cancer Center (UWCCC) researchers.
Study: Medicaid expansion helped reduce reliance on federal income assistance
States that expanded Medicaid under the Affordable Care Act saw a reduction in reliance on a federal income assistance program for low-income adults with disabilities, according to a study from the UW School of Medicine and Public Health.